CONCLUSIONS The intrapleural administration of streptokinase does not improve mortality, the rate of surgery, or the length of the hospital stay among patients with pleural infection.
CONCLUSIONS The intrapleural administration of streptokinase does not improve mortality, the rate of surgery, or the length of the hospital stay among patients with pleural infection.
结论在胸膜感染的病人中，链激酶胸膜腔内给药不能改善死亡率、手术率或住院时间的长短。